Synaptogenix Inc (SNPX)

[Cyosol]

That "interesting" trial design sure sounds like data manipulation to me.

If patients improve by taking sugar water you either have a bad trial design or you're dealing with a disease that can be cured with sugar water.

Because Alzheimer's is a real disease with no cure, there's only one explanation for why placebo patients performed well and it's because the trial was too short and the scale used for measuring patients is flawed.

Almost all AD companies measure patients by having them answer questionnaires rather than measure meaningful biomarkers, for the simple reason that we currently don't know of any better way to measure the decline.

They tried with amyloid and that clearly didn't work.